Page 2822 - Cote clinical veterinary advisor dogs and cats 4th
P. 2822

Imipenem-cilastatin (Primaxin)                                                       Insulin, detemir (Levemir)   1485



            Generic Name (Brand                                                               Administration/
            Name, Synonyms)    Canine Dosages      Feline Dosages      Adverse Effects/Warnings  Availability
  VetBooks.ir  Imipenem-cilastatin   Susceptible infections:   Susceptible infections:   Use with caution in renal impairment   Powder for injection;
                                5-10 mg/kg IV q 6-8h
                                                    5-10 mg/kg IV q 6-8h
                                                                        (dosage adjustment may be
                                                                                                reconstituted imipenem
              (Primaxin)
                                                                                                solution should be further
                                                                        required) and in CNS disorders
                                                                        (e.g., seizures, head trauma).
                                                                                                solution and infused over
                                                                        Adverse effects include GI upset,   diluted in a compatible IV
                                                                        CNS toxicity (seizures, tremors),   20-60 minutes.
                                                                        hypersensitivity, and infusion
                                                                        reactions (thrombophlebitis). Too
                                                                        rapid IV infusions may cause GI
                                                                        or CNS toxicity, or other untoward
                                                                        effects. Rarely, increases in serum
                                                                        creatinine, BUN, hepatic enzymes,
                                                                        hypotension, and tachycardia have
                                                                        been reported.
            Imipramine (Tofranil)  Narcolepsy/cataplexy:   Behavioral modification:   Anticholinergic side effects are   Tablets, capsules
                                0.5-1 mg/kg PO q 8-12h  0.5-1 mg/kg PO q 12-24h  common. Do not use with MAO
                               Behavioral disorders:   Urethral incompetence:   inhibitors (e.g., amitraz). May
                                2.2-4.4 mg/kg PO q 24h  2.5-5 mg/CAT PO q 12h  lower seizure threshold. Use with
                               Urethral incompetence:                   caution in patients with thyroid
                                5-15 mg/DOG PO q 12h                    disorders, urinary retention,
                                                                        hepatic disorders, KCS, glaucoma,
                                                                        cardiac rhythm disorders,
                                                                        DM, or adrenal tumors due to
                                                                        anticholinergic adverse effects.
            Immunoglobulin (IGIV, IVIG,   Immune-mediated blood   Dosing in cats is not described.  Adverse effects are often associated   Injection; infused over a
              hIVIG)            disorder: 0.5-1.5 g/kg IV               with too rapid IV administration   6- to 12-hour period. Very
                                over 6-12 hours                         (administer over 6-12 hours).   expensive.
                                                                        Can cause anaphylaxis, perhaps
                                                                        associated with trace amounts
                                                                        of human albumin. Can cause
                                                                        increased blood pressure or
                                                                        local reactions at or near the
                                                                        injection site. Volume overload
                                                                        is possible. IVIG may promote
                                                                        hypercoagulability and an
                                                                        inflammatory state.
            Insulin, regular (Humulin-R,   DKA or hyperosmolar   DKA: Prepare in saline   Hypoglycemia is most important   Injection. To prepare CRI,
              Novolin-R)        syndrome: 0.2 units/  as described (see   adverse effect. Other adverse   add 1.1 units/kg (cat) or
                                kg/h IV CRI, or prepare in   administration), and begin   effects include insulin-induced   2.2 units/kg (dog) to bag of
                                saline as described (see   infusion at 10 mL/h IV CRI,   hyperglycemia (Somogyi effect),   0.9% saline then run diluted
                                administration) and begin   adjusting prn based on   insulin antagonism/resistance,   insulin solution through
                                infusion at 10 mL/h IV CRI,   frequent glucose assessment   rapid insulin metabolism, and   IV tubing and discard the
                                adjusting prn based on   (see Diabetic Ketoacidosis).   local hypersensitivity reactions.  first 50 mL of fluid (due
                                frequent glucose assessment   Dextrose supplementation          to adsorption onto plastic
                                (see Diabetic Ketoacidosis).   begun when glucose is <250;      tubing) before attaching to
                                Dextrose supplementation   or intermittent IM dosing            the patient.
                                begun when glucose   as for dog starting with
                                is <250. Alternative   0.1 units/kg
                                intermittent IM dosing:    Hyperkalemia:   1 4  units/kg IV
                                0.1-0.2 units/kg IM   bolus, or 1 units/CAT with
                                into muscles of the rear   dextrose supplementation (2 g
                                legs; repeat IM doses of   dextrose per unit of insulin,
                                0.1 units/kg q 1h until   1 2  by bolus and   1 2  in IV
                                glucose <250 mg/dL, then   fluids)
                                IM q 4-6h or SQ q 6-8h
                                until ready to switch to
                                longer-acting insulin upon
                                return of appetite
            Insulin, detemir (Levemir)  DM: 0.1 units/kg SQ q 12h,   DM: 0.25 units/kg SQ q 12h,   Hypoglycemia is most important   Injection; use U100 syringes
                                adjusted prn. Rarely used   adjusted prn. Rarely used   adverse effect. More potent in   for injection. Vial should be
                                in dogs.            in cats.            dogs than other commonly used   rolled to mix and not shaken.
                                                                        insulin types. Other adverse   Also available as insulin pen.
                                                                        effects include insulin-induced
                                                                        hyperglycemia (Somogyi effect),
                                                                                                                      Drug Compendium
                                                                        insulin antagonism/resistance,
                                                                        rapid insulin metabolism, and
                                                                        local hypersensitivity reactions.




                                                      www.ExpertConsult.com
   2817   2818   2819   2820   2821   2822   2823   2824   2825   2826   2827